High Outlier
Strength
155 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458057501
Classification
Brand
Dosage Form
GRANULE, FOR SUSPENSION
Route
ORAL
Last Updated
2/3/2026
Active Ingredients
RIVAROXABANApproval Type
New Drug (NDA)
FDA Application
NDA215859On Market Since
12/1/2021
Pharmacological Classes
Factor Xa Inhibitor
Factor Xa Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
ELIQUIS 2.5 MG TABLET
Brand
00003089321•E.R. Squibb & Sons, L.L.C.
$5.5232
per EA
ELIQUIS 2.5 MG TABLET
Brand
00003089331•E.R. Squibb & Sons, L.L.C.
$5.5232
per EA
ELIQUIS 5 MG TABLET
Brand
00003089421•E.R. Squibb & Sons, L.L.C.
$5.5265
per EA
ELIQUIS 5 MG TABLET
Brand
00003089431•E.R. Squibb & Sons, L.L.C.
$5.5265
per EA
ELIQUIS 5 MG TABLET
Brand
00003089470•E.R. Squibb & Sons, L.L.C.
$5.5265
per EA
SAVAYSA 60 MG TABLET
Brand
65597020305•Daiichi Sankyo Inc.
$12.4609
per EA
SAVAYSA 60 MG TABLET
Brand
65597020390•Daiichi Sankyo Inc.
$12.4609
per EA
SAVAYSA 30 MG TABLET
Brand
65597020205•Daiichi Sankyo Inc.
$12.4819
per EA
SAVAYSA 30 MG TABLET
Brand
65597020290•Daiichi Sankyo Inc.
$12.4819
per EA
SAVAYSA 30 MG TABLET
Brand
65597020230•Daiichi Sankyo Inc.
$14.5678
per EA